GlassScriptPhysician profile
Lorraine Tolbert
NPI 1427328921
$7,055.85
in general payments reported to CMS, 2019-2025
44 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,788 · 2022: $2,492 · 2023: $1,484 · 2024: $167 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,361.19 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $404.08 | 2021-2023 | Trintellix |
| Lilly USA, LLC | $369.11 | 2021-2023 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $365.64 | 2021-2024 | Rexulti, Abilify Maintena |
| Amgen INC. | $351.11 | 2021-2023 | Repatha, Otezla |
| Biohaven Pharmaceuticals, INC. | $319.12 | 2021 | |
| Novo Nordisk INC | $310.55 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $278.80 | 2021-2023 | Xarelto |
| Corium, LLC | $229.79 | 2023 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $204.40 | 2021-2023 | |
| Pfizer INC. | $202.56 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $201.27 | 2021-2023 | Verquvo, Belsomra, Januvia |
| Glaxosmithkline, LLC. | $184.88 | 2021-2023 | Trelegy Ellipta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $183.88 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $179.96 | 2021-2023 | Seglentis, Livalo |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Tolbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.